Sangamo Therapeutics Announces Participation at the Jefferies Virtual Healthcare Conference

May 29, 2020 at 9:00 AM EDT

BRISBANE, Calif.--(BUSINESS WIRE)--May 29, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 4:00 p.m. ET.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit

Investor Relations – Global
McDavid Stilwell
510-970-6000, x219

Source: Sangamo Therapeutics, Inc.